Management of patients with antiphospholipid antibodies or antiphospholipid syndrome during pregnancy

Key Points

• This research addresses the management challenges of patients with antiphospholipid antibodies during pregnancy and aims to improve outcomes.
• Review of current understanding of obstetric APS
• Analysis of therapeutic targets related to placental inflammation
• Discussion of multidisciplinary approaches to care
• Identified placental inflammation as a target for potential interventions
• Highlighted the need for risk-stratified management
• Emphasized the limitations in standardized treatment protocols